题名

醫師對安寧緩和病人接受新冠狀病毒疫苗的共識調查:南部某醫學中心經驗

并列篇名

Consensus among Physicians towards Covid-19 Vaccination for Hospice and Palliative Patients: A study at a Medical Center in Southern Taiwan

DOI

10.6537/TJHPC.202211_26(3).01

作者

陳朝棟(Chou-Tung Chen);黃偉城(Wei-Cheng Huang);陳潔宜(Chieh-I Chen);黃琨祥(Kun-Siang Huang);陳暉明(Hui-Ming Chen);王培銘(Pei-Ming Wang);林宏昇(Hung-Sheng Lin);陳偉熹(Wei-Hsi Chen)

关键词

嚴重特殊傳染性肺炎 ; 新冠狀病毒疫苗 ; 安寧緩和 ; 自主 ; 疫苗猶疑 ; Coronavirus Disease 2019 ; new coronavirus vaccine ; hospice and palliation ; autonomy ; vaccine hesitancy

期刊名称

安寧療護雜誌

卷期/出版年月

26卷3期(2022 / 11 / 01)

页次

205 - 223

内容语文

繁體中文

中文摘要

研究目的:接種新冠狀病毒疫苗是目前減少嚴重特殊傳染性肺炎發生和死亡的方法之一。雖然研究證實慢性病病人被感染和感染後死亡的機率較一般人為高,專家也呼籲慢性病人接受疫苗接種之重要性,卻沒有關於醫療人員對安寧緩和病人接種疫苗之意見調查,可能因此忽視了安寧緩和病人的接種意願和權益。研究方法:本研究由作者群自行設計不同安寧緩和的虛擬情境,從準備預立安寧緩和醫療暨維生之意願至生命末期,病人分別處在意識清楚或意識不清楚之狀況,由病人本人或家屬提出疫苗接種的要求,調查醫師對病人接種疫苗的看法和疫苗廠牌的偏好。本研究的參加者是在臺灣南部某醫學中心服務,必須接受符合規定的安寧緩和訓練。研究結果:分析顯示醫師對安寧緩和病人接受疫苗接種,大多持正向和支持的看法。重要影響因素有安寧緩和預後程度、臨床適合度、自主表現和疫苗傷害。另外,在整體上醫師對疫苗廠牌沒有特殊偏好。結論:建議政府和學會應該盡快建立關於疫苗接種之醫療照顧和教育的準則,保障安寧緩和病人權益。

英文摘要

Purpose: Vaccination is an effective method to reduce the occurrence and mortality of the Coronavirus Disease 2019 (COVID-19) pandemic. Overwhelming studies have revealed the frequency of COVID-19 infections and post-infectious mortality to be higher in persons with chronic diseases than without them. In addition, specialists also call civilians to receive full vaccination. However, there is a shortage of information concerning the vaccination in patients receiving hospice and palliative care. A wrong message may let patients receiving hospice and palliative care to lose their opportunity and protection for vaccination. Method: In this study, authors designed different scenarios ranging from preparing to complete the letter of intent for the choice for hospice palliative care and life-sustaining treatment to end-of-life hospice care. The virtual patients were conscious or unconscious, and either virtual patients or their family requested vaccination. The aim of this study was to investigate the attitude of physicians for vaccination and selection of label in patients receiving hospice and palliative care. Participants were from a single medical center at south Taiwan and had received standard hospice/palliative training. Result: Results showed that most of the physicians expressed a positive and supportive attitude for vaccination in patients receiving hospice and palliative care. The influential factors included the severity of hospice/palliation level, the suitability of clinical conditions, autonomous performance and vaccine harm. Moreover, physicians did not show preference for any label. Conclusion: We suggest government and medical association to setup the principles of medical care and education for COVID-19 vaccination in order to protect the right of patients receiving hospice and palliative care.

主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. Ahn, DG,Shin, HJ,Kim, MH(2020).Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease. 2019 (COVID-19).J Microbiol Biotechnol,30(3),313-324.
  2. Asadi-Pooya, AA,Sahraian, A,Badv, RS,Sahraian, MA(2021).Physicians’ opinions on the necessity of COVID-19 vaccination in patients with epilepsy.Epileptic Disord,23(3),485-489.
  3. Center Disease Control: COVID-19 Treatment Guidelines. Therapies. Available at https://www.covid19treatmentguidelines.nih.gov/therapies. Accessed May 13, 2022.
  4. Chavez-MacGregor, M,Lei, X,Zhao, H,Scheet, P,Giordano, SH(2021).Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer.JAMA Oncol,28,e215148.
  5. Congressional Research Service.,未出版
  6. Daskalakis, G,Pergialiotis, V,Antsaklis, P,Theodora, M,Papageorgiou, D,Rodolakis, A.Healthcare workers’ attitudes about vaccination of pregnant women and those wishing to become pregnant.J Perinat Med
  7. Day, P,Strenth, C,Kale, N,Schneider, FD,Arnold, EM(2021).Perspectives of primary care physicians on acceptance and barriers to COVID-19 vaccination.Fam Med Community Health,9(4),e001228.
  8. Devakumar, D,Shannon, G,Bhopal, SS,Abubakar, I(2020).Racism and discrimination in COVID-19 responses.Lancet,395(10231),1194.
  9. Duch, R,Roope, LSJ,Violato, M(2021).Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.Proc Natl Acad Sci U S A,118(38),e2026382118.
  10. Duong, MC,Nguyen, HT,Duong, BT(2021).Who influences the public intention to get a COVID-19 vaccine and what are the public references and concerns? A population survey in Vietnam.Infect Chemother,53(4),753-766.
  11. Gundavda, MK,Gundavda, KK(2021).Cancer or COVID-19? A review of recommendations for COVID-19 vaccination in cancer patients.Curr Treat Options Oncol,22(10),95.
  12. Harman, S,Erfani, P,Goronga, T,Hickel, J,Morse, M,Richardson, ET(2021).Global vaccine equity demands reparative justice - not charity.BMJ Glob Health,6(6),e006504.
  13. Hasseli, R,Pfeil, A,Krause, A(2021).A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany.Rheumatol Int,41(11),1949-1956.
  14. Houska, A,Loučka, M(2019).Patients' Autonomy at the end of life: A critical review.J Pain Symptom Manage,57(4),835-845.
  15. Hsieh, SM,Liu, MC,Chen, YH(2021).Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.Lancet Respir Med,9(12),1396-1406.
  16. International Monetary Fund(2021).World Economic Outlook Report.
  17. Jdiaa, SS,Mansour, R,El Alayli, A,Gautam, A,Thomas, P,Mustafa, RA(2022).COVID-19 and chronic kidney disease: an updated overview of reviews.J Nephrol,35(1),69-85.
  18. Jecker, NS.Global sharing of COVID-19 vaccines: A duty of justice, not charity.Dev World Bioeth
  19. Khan, WH,Hashmi, Z,Goel, A(2021).COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.Front Cell Infect Microbiol,11,690621.
  20. Kim, M,Liu, S,Lee, Y,Shrader, CH,Kanamori, M(2022).COVID-19 Related Racial Discrimination in Small Asian Communities: A Cross Sectional Study.J Immigr Minor Health,24(1),38-47.
  21. Kose, S,Mandiracioglu, A,Sahin, S,Kaynar, T,Karbus, O,Ozbel, Y(2021).Vaccine hesitancy of the COVID-19 by health care personnel.Int J Clin Pract,75,e13917.
  22. Kukreti, S,Lu, MY,Lin, YH(2021).Willingness of Taiwan’s healthcare workers and outpatients to vaccinate against COVID-19 during a period without community outbreaks.Vaccines,9(3),246.
  23. Kumar, R,Beniwal, K,Bahurupi, Y,Kant, R,Bairwa, M(2021).Determinants of COVID-19 vaccination willingness among health care workers: A quick online survey in India.Korean J Fam Med,42(6),445-452.
  24. Li, H,Zhou, Y,Zhang, M,Wang, H,Zhao, Q,Liu, J(2020).Updated approaches against SARS-CoV-2.Antimicrob Agents Chemother,64(6),e00483-20.
  25. Li, M,Luo, Y,Watson, R.Healthcare workers’ (HCWs) attitudes and related factors towards COVID-19 vaccination: a rapid systematic review.Postgrad Med J
  26. Mahamat-Saleh, Y,Fiolet, T(2021).Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies.BMJ Open,11(10),e052777.
  27. Mahamat-Saleh, Y,Fiolet, T,Rebeaud, ME(2021).Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies.BMJ Open,1(10),e052777.
  28. Mauri, D,Kamposioras, K,Tolia, M,Alongi, F,Tzachanis, D,International Oncology Panel,European Cancer Patient Coalition collaborators(2020).Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.Lancet Oncol,21(6),759-760.
  29. Mohseni Afshar, Z,Babazadeh, A,Janbakhsh, A(2021).Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.Rev Med Virol,22,e2309.
  30. Our World in Data. Share of people vaccinated against COVID-19, Mar 13, 2022. Available at https://ourworldindata.org/explorers/coronavirus-data-explorer?zoomToSelection=true&facet=none&pickerSort=desc&pickerMetric=total_vaccinations_per_hundred&Metric=People+vaccinated+%28by+dose%29&Interval=7-day+rolling+average&Relative+to+Population=true&Color+by+test+positivity=false&country=TWN~SGP~KOR~FRA~GBR~DEU~USA. Accessed May 13, 2022.
  31. Pak, A,Adegboye, OA,Adekunle, AI,Rahman, KM,McBryde, ES,Eisen, DP(2020).Economic Consequences of the COVID-19 Outbreak: the Need for Epidemic Preparedness.Front Public Health,8,241.
  32. Paterson, P,Meurice, F,Stanberry, LR,Glismann, S,Rosenthal, SL,Larson, HJ(2016).Vaccine hesitancy and healthcare providers.Vaccine,34(52),6700-6706.
  33. Poon, PKM,Zhou, W,Chan, DCC,Kwok, KO,Wong, SYS(2021).Recommending COVID-19 vaccines to patients: Practice and concerns of frontline family doctors.Vaccines,9(11),1319.
  34. Sahni, S,Gupta, G,Sarda, R,Pandey, S,Pandey, RM,Sinha, S(2021).Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis.Diabetes Metab Syndr,15(6),102308.
  35. Sirikalyanpaiboon, M,Ousirimaneechai, K,Phannajit, J(2021).COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand.BMC Infect Dis,21(1),1174.
  36. Statistics Canada. Experiences of discrimination during the COVID-19 pandemic. Available at https://www150.statcan.gc.ca/n1/daily-quotidien/200917/dq200917a-eng.htm. Accessed May 13, 2022.
  37. Talic, S,Shah, S,Wild, H(2021).Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.BMJ,375,e068302.
  38. World Health Organization: Coronavirus disease (COVID-19). Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed January 17, 2022.
  39. 衛生福利部。110 年簽署人數統計。2022年 1 月 14 日。取自https://hpcod.mohw.gov.tw/HospWeb/RWD/Statistics/calc_report.aspx?year=2021。
  40. 衛生福利部。各類 COVID-19 疫苗接種對象累計接種人次與各縣市 COVID-19疫苗接種率(累計至 111 年 1 月 10 日止)。2022 年 1 月 14 日。取自https://www.cdc.gov.tw/File/Get/aSemzyKaCHC-l-uider03w。